Alta Sciences

DECEMBER 14, 2023

A Closer Look At Our On-Site Compounding Pharmacies shajjar Thu, 12/14/2023 - 21:30 HTML Altasciences' dedicated pharmacists bring a wealth of expertise in controlled substances and complex compounding, ensuring maximum precision and safety standards. Electronic security access to the pharmacy and video monitoring. -

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

Alta Sciences

MAY 15, 2023

TOP 5 WAYS INTEGRATED DRUG DEVELOPMENT SOLUTIONS SAVE YOU TIME AND MONEY aasimakopoulos Mon, 05/15/2023 - 16:06 Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 billion , without, for the most part, shorter development timelines. Altasciences has U.S.

Drug Development 52

Drug Development Clinical Trials Compounding Pharmacies Laboratories 52

Agency IQ

MARCH 25, 2024

Requirements for 503A pharmacies have since been updated, most notably under the Drug Quality and Security Act ( DQSA ) of 2013, which established new requirements for 503A pharmacies as well as a new category of compounding pharmacies, known as outsourcing facilities (503B pharmacies). suppositories).

FDA 40

FDA Pharmacy Production Drugs 40

The Pharma Data

MAY 7, 2021

Massachusetts sues Publicis for designing ‘marketing schemes’ to boost OxyContin sales ( STAT ). Goldman Sachs jumps aboard Bain-backed 503(b) compounding pharmacy with a $275M debt loan to supply hospitals ( Endpoints ). The US opened pandora’s box on IP waivers for Covid-19 vaccines.

Vaccine 52

Vaccine Compounding Pharmacies Regulations Drugs 52

Agency IQ

FEBRUARY 15, 2024

Priority A List. The guidance will provide a comprehensive, systematic and stepwise approach with examples, when applicable, to illustrate how to make this determination. The guidance will cover best practices for information submission and other communications.

FDA 40

FDA Science Biosimilars Clinical Trials 40

Agency IQ

AUGUST 25, 2023

Delta-9 THC is a compound present in higher quantities in marijuana than hemp, and has traditionally been considered responsible f or the psychoactive properties of marijuana. And as companies wishing to market CBD products have discovered, there are several FDA requirements that are proving especially cumbersome.

Regulations 40

Regulations FDA Science Production 40